Gastrointestinal Therapeutics Market Report

Global and Region Gastrointestinal Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：189
  • REPORT CODE：GMM886976
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gastrointestinal Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Therapeuticsmarket, defines the market attractiveness level of Gastrointestinal Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastrointestinal Therapeutics industry, describes the types of Gastrointestinal Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Therapeutics market and the development prospects and opportunities of Gastrointestinal Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Therapeutics market in Chapter 13.

    By Player:

    • F Hoffmann-La Roche

    • Novartis

    • Procter & Gamble

    • Johnson & Johnson

    • Pfizer

    • Shire Pharmaceuticals

    • Merck

    • Allergan

    • GlaxoSmithKline

    • Eli Lilly

    • Tillotts Pharma

    • Amgen

    • AbbVie

    • AstraZeneca

    • Takeda

    By Type:

    • Oral

    • Parenteral

    By End-User:

    • IBD

    • Irritable Bowel Syndrome (IBS)

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastrointestinal Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastrointestinal Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastrointestinal Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastrointestinal Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastrointestinal Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Gastrointestinal Therapeutics Consumption (2017-2022)

    • 7.2 United States Gastrointestinal Therapeutics Consumption (2017-2022)

    • 7.3 Europe Gastrointestinal Therapeutics Consumption (2017-2022)

    • 7.4 China Gastrointestinal Therapeutics Consumption (2017-2022)

    • 7.5 Japan Gastrointestinal Therapeutics Consumption (2017-2022)

    • 7.6 India Gastrointestinal Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Gastrointestinal Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Gastrointestinal Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Gastrointestinal Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Gastrointestinal Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Gastrointestinal Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Gastrointestinal Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Gastrointestinal Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Gastrointestinal Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastrointestinal Therapeutics Consumption Forecast (2022-2028)

    9 Global Gastrointestinal Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastrointestinal Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Parenteral Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastrointestinal Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global IBD Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    10 Global Gastrointestinal Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastrointestinal Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastrointestinal Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global IBD Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastrointestinal Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastrointestinal Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastrointestinal Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastrointestinal Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastrointestinal Therapeutics Market Competitive Analysis

    • 14.1 F Hoffmann-La Roche

      • 14.1.1 F Hoffmann-La Roche Company Details

      • 14.1.2 F Hoffmann-La Roche Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 F Hoffmann-La Roche Gastrointestinal Therapeutics Product and Service

    • 14.2 Novartis

      • 14.2.1 Novartis Company Details

      • 14.2.2 Novartis Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis Gastrointestinal Therapeutics Product and Service

    • 14.3 Procter & Gamble

      • 14.3.1 Procter & Gamble Company Details

      • 14.3.2 Procter & Gamble Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Procter & Gamble Gastrointestinal Therapeutics Product and Service

    • 14.4 Johnson & Johnson

      • 14.4.1 Johnson & Johnson Company Details

      • 14.4.2 Johnson & Johnson Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Johnson & Johnson Gastrointestinal Therapeutics Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Gastrointestinal Therapeutics Product and Service

    • 14.6 Shire Pharmaceuticals

      • 14.6.1 Shire Pharmaceuticals Company Details

      • 14.6.2 Shire Pharmaceuticals Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Shire Pharmaceuticals Gastrointestinal Therapeutics Product and Service

    • 14.7 Merck

      • 14.7.1 Merck Company Details

      • 14.7.2 Merck Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck Gastrointestinal Therapeutics Product and Service

    • 14.8 Allergan

      • 14.8.1 Allergan Company Details

      • 14.8.2 Allergan Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Allergan Gastrointestinal Therapeutics Product and Service

    • 14.9 GlaxoSmithKline

      • 14.9.1 GlaxoSmithKline Company Details

      • 14.9.2 GlaxoSmithKline Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline Gastrointestinal Therapeutics Product and Service

    • 14.10 Eli Lilly

      • 14.10.1 Eli Lilly Company Details

      • 14.10.2 Eli Lilly Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Eli Lilly Gastrointestinal Therapeutics Product and Service

    • 14.11 Tillotts Pharma

      • 14.11.1 Tillotts Pharma Company Details

      • 14.11.2 Tillotts Pharma Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Tillotts Pharma Gastrointestinal Therapeutics Product and Service

    • 14.12 Amgen

      • 14.12.1 Amgen Company Details

      • 14.12.2 Amgen Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Amgen Gastrointestinal Therapeutics Product and Service

    • 14.13 AbbVie

      • 14.13.1 AbbVie Company Details

      • 14.13.2 AbbVie Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 AbbVie Gastrointestinal Therapeutics Product and Service

    • 14.14 AstraZeneca

      • 14.14.1 AstraZeneca Company Details

      • 14.14.2 AstraZeneca Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 AstraZeneca Gastrointestinal Therapeutics Product and Service

    • 14.15 Takeda

      • 14.15.1 Takeda Company Details

      • 14.15.2 Takeda Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Takeda Gastrointestinal Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastrointestinal Therapeutics

    • Figure Gastrointestinal Therapeutics Picture

    • Table Global Gastrointestinal Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastrointestinal Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastrointestinal Therapeutics Consumption by Country (2017-2022)

    • Figure United States Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Parenteral Consumption and Growth Rate (2017-2022)

    • Figure Global IBD Consumption and Growth Rate (2017-2022)

    • Figure Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IBD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastrointestinal Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastrointestinal Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Gastrointestinal Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Gastrointestinal Therapeutics Product and Service

    • Table Procter & Gamble (Foundation Year, Company Profile and etc.)

    • Table Procter & Gamble Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Procter & Gamble Gastrointestinal Therapeutics Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Gastrointestinal Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Gastrointestinal Therapeutics Product and Service

    • Table Shire Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Shire Pharmaceuticals Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Pharmaceuticals Gastrointestinal Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Gastrointestinal Therapeutics Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Gastrointestinal Therapeutics Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Gastrointestinal Therapeutics Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Gastrointestinal Therapeutics Product and Service

    • Table Tillotts Pharma (Foundation Year, Company Profile and etc.)

    • Table Tillotts Pharma Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tillotts Pharma Gastrointestinal Therapeutics Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Gastrointestinal Therapeutics Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Gastrointestinal Therapeutics Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Gastrointestinal Therapeutics Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Gastrointestinal Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US